98 related articles for article (PubMed ID: 15936073)
1. S100P is selectively upregulated in tumor cell lines challenged with DNA cross-linking agents.
Jiang F; Shults K; Flye L; Hashimoto Y; Van Der Meer R; Xie J; Kravtsov V; Price J; Head DR; Briggs RC
Leuk Res; 2005 Oct; 29(10):1181-90. PubMed ID: 15936073
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of GSTA2 protects against cell cycle arrest and apoptosis induced by the DNA inter-strand crosslinking nitrogen mustard, mechlorethamine.
Xie J; Shults K; Flye L; Jiang F; Head DR; Briggs RC
J Cell Biochem; 2005 May; 95(2):339-51. PubMed ID: 15778998
[TBL] [Abstract][Full Text] [Related]
3. Expression of the calcium-binding protein S100P is regulated by bone morphogenetic protein in pancreatic duct epithelial cell lines.
Hamada S; Satoh K; Hirota M; Fujibuchi W; Kanno A; Umino J; Ito H; Satoh A; Kikuta K; Kume K; Masamune A; Shimosegawa T
Cancer Sci; 2009 Jan; 100(1):103-10. PubMed ID: 19018761
[TBL] [Abstract][Full Text] [Related]
4. S100P expression in human esophageal epithelial cells: Human esophageal epithelial cells sequentially produce different S100 proteins in the process of differentiation.
Sato N; Hitomi J
Anat Rec; 2002 May; 267(1):60-9. PubMed ID: 11984793
[TBL] [Abstract][Full Text] [Related]
5. Expression of S100P gene in cervical carcinoma cells is independent of E7 human papillomavirus oncogene.
Jakubícková L; Baráthová M; Pastoreková S; Pastorek J; Gibadulinová A
Acta Virol; 2005; 49(2):133-7. PubMed ID: 16047742
[TBL] [Abstract][Full Text] [Related]
6. S-phase reduction in T47D human breast cancer epithelial cells induced by an S100P antisense-retroviral construct.
Beissel B; Silva ID; Pesquero JB; Russo J; Schor N; Bellini MH
Oncol Rep; 2007 Mar; 17(3):611-5. PubMed ID: 17273741
[TBL] [Abstract][Full Text] [Related]
7. Placental S100 (S100P) and GATA3: markers for transitional epithelium and urothelial carcinoma discovered by complementary DNA microarray.
Higgins JP; Kaygusuz G; Wang L; Montgomery K; Mason V; Zhu SX; Marinelli RJ; Presti JC; van de Rijn M; Brooks JD
Am J Surg Pathol; 2007 May; 31(5):673-80. PubMed ID: 17460449
[TBL] [Abstract][Full Text] [Related]
8. S100P promotes pancreatic cancer growth, survival, and invasion.
Arumugam T; Simeone DM; Van Golen K; Logsdon CD
Clin Cancer Res; 2005 Aug; 11(15):5356-64. PubMed ID: 16061848
[TBL] [Abstract][Full Text] [Related]
9. Bifunctional alkylating agent-induced p53 and nonclassical nuclear factor kappaB responses and cell death are altered by caffeic acid phenethyl ester: a potential role for antioxidant/electrophilic response-element signaling.
Minsavage GD; Dillman JF
J Pharmacol Exp Ther; 2007 Apr; 321(1):202-12. PubMed ID: 17204746
[TBL] [Abstract][Full Text] [Related]
10. Differences between melphalan and nitrogen mustard in the formation and removal of DNA cross-links.
Ross WE; Ewig RA; Kohn KW
Cancer Res; 1978 Jun; 38(6):1502-6. PubMed ID: 565677
[TBL] [Abstract][Full Text] [Related]
11. S100P sensitizes ovarian cancer cells to carboplatin and paclitaxel in vitro.
Wang Q; He Z; Gao J; Hu S; Huang M; Liu M; Zheng J; Tang H
Cancer Lett; 2008 Dec; 272(2):277-84. PubMed ID: 18762368
[TBL] [Abstract][Full Text] [Related]
12. Cytoskeleton vimentin disruption of mouse sertoli cells injured by nitrogen mustard in vitro.
He D; Zhang D; Wei G; Lin T; Li X
J Androl; 2007; 28(3):389-96. PubMed ID: 17192600
[TBL] [Abstract][Full Text] [Related]
13. Transcriptional regulation and functional implication of S100P in cancer.
Gibadulinova A; Tothova V; Pastorek J; Pastorekova S
Amino Acids; 2011 Oct; 41(4):885-92. PubMed ID: 20155429
[TBL] [Abstract][Full Text] [Related]
14. Key promoter elements involved in transcriptional activation of the cancer-related gene coding for S100P calcium-binding protein.
Gibadulinova A; Oveckova I; Parkkila S; Pastorekova S; Pastorek J
Oncol Rep; 2008 Aug; 20(2):391-6. PubMed ID: 18636203
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of cyclin B1 and up-regulation of Wee1 by berberine promotes entry of leukemia cells into the G2/M-phase of the cell cycle.
Lin CC; Lin SY; Chung JG; Lin JP; Chen GW; Kao ST
Anticancer Res; 2006; 26(2A):1097-104. PubMed ID: 16619512
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of DNA topoisomerase IIalpha leads to prolonged cell cycle transit in G2 and early M phases and increased survival to microtubule-interacting agents.
Skladanowski A; Côme MG; Sabisz M; Escargueil AE; Larsen AK
Mol Pharmacol; 2005 Sep; 68(3):625-34. PubMed ID: 15942022
[TBL] [Abstract][Full Text] [Related]
17. DNA reactivity and in vitro cytotoxicity of the novel antitumor agent 1,5,2,4-dioxadithiepane-2,2,4,4-tetraoxide (NSC-348948) in human embryo cells.
Gibson NW; Hartley JA; Kohn KW
Cancer Res; 1986 Apr; 46(4 Pt 1):1679-83. PubMed ID: 3509975
[TBL] [Abstract][Full Text] [Related]
18. Differential expression of calcium-related genes in gastric cancer cells transfected with cellular prion protein.
Liang J; Luo G; Ning X; Shi Y; Zhai H; Sun S; Jin H; Liu Z; Zhang F; Lu Y; Zhao Y; Chen X; Zhang H; Guo X; Wu K; Fan D
Biochem Cell Biol; 2007 Jun; 85(3):375-83. PubMed ID: 17612632
[TBL] [Abstract][Full Text] [Related]
19. Heterodimeric interaction and interfaces of S100A1 and S100P.
Wang G; Zhang S; Fernig DG; Spiller D; Martin-Fernandez M; Zhang H; Ding Y; Rao Z; Rudland PS; Barraclough R
Biochem J; 2004 Aug; 382(Pt 1):375-83. PubMed ID: 15171681
[TBL] [Abstract][Full Text] [Related]
20. Immediate up-regulation of the calcium-binding protein S100P and its involvement in the cytokinin-induced differentiation of human myeloid leukemia cells.
Ishii Y; Kasukabe T; Honma Y
Biochim Biophys Acta; 2005 Sep; 1745(2):156-65. PubMed ID: 16129123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
